Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations

BACKGROUND: While surgery is the first-line treatment for patients with endogenous hypercortisolism (Cushing syndrome [CS]), mifepristone has been shown to be a beneficial medical treatment option, as demonstrated in the SEISMIC (Study of the Efficacy and Safety of Mifepristone in the Treatment of E...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Diabetes Endocrinol
Главные авторы: Brown, David R., East, Honey E., Eilerman, Bradley S., Gordon, Murray B., King, Elizabeth E., Knecht, Laura A., Salke, Brandon, Samson, Susan L., Yuen, Kevin C. J., Yau, Hanford
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2020
Предметы:
Review Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7596972/
https://ncbi.nlm.nih.gov/pubmed/33292727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40842-020-00105-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы